|
|
401 W. Morgan Rd.
Ann Arbor, MI 48108 USA
phone:734.272.4772
fax:734.272.4778
|
|
| Symbol |
Private |
| Founded |
2007 |
| Employees |
|
|
|
| www.nephrion.com
|
|
|
|
 |
| Summary Description |
| Medical devices for treating unmet medical needs |
|
| Management |
| Jim Danehy, CEO; Dr. H. David Humes, CSO; Mark Morsfield, BBA, MBA, CFO; Joseph Sobota, M.D., CMO; Dirk Schipper, BS, MBA, VP Manufacturing |
| |
|
|
| |
|
| Keywords |
| end stage renal disease, ESRD, acute renal failure, ARF, cardio-pulmonary bypass surgery |
|
|
|
| Description |
|
Nephrion, Inc. is a dynamic venture-backed life sciences company headquartered in Ann Arbor, Michigan whose principal technology consists of medical devices for treating several large unmet medical needs, including End Stage Renal Disease (ESRD), Acute Renal Failure (ARF) and other acute inflammatory indications: Cardio-Pulmonary Bypass Surgery (CPB), Sepsis, Systemic Inflammatory Response Syndrome (SIRS) and Acute Respiratory Distress Syndrome (ARDS). These markets add up to several billion dollars of market opportunity for Nephrion given the underlying rise in diabetes, kidney failure and inflammatory disease patients from the aging population. The management team and our investors are organized to create a first in class firm to provide new therapies to these large unmet medical needs. |
|
| Technology / Differentiation |
| Nephrions current products are based on intellectual property developed by Dr. Humes and also acquired from RenaMed Biologics, Inc. in a purchase of its assets in 2007. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members